ESOMEP-EZS (esomeprazole magnesium/glycerin)
20 mg capsule delayed release with spray to ease swallowing
- Dosage information is not available
- atazanavir
- Complera
- Edurant
- emtricitab-rilpivirine-tenofov
- nelfinavir
- Reyataz
- rilpivirine
- Viracept
Contraindicated
- Bosulif
- bosutinib
- Cellcept
- Cellcept Intravenous
- citalopram
- clobazam
- clopidogrel
- dasatinib
- erlotinib
- itraconazole
- ketoconazole
- methotrexate sodium
- methotrexate sodium (PF)
- mycophenolate mofetil
- mycophenolate mofetil HCl
- nilotinib
- Noxafil
- Onfi
- Onmel
- Plavix
- posaconazole
- Sporanox
- Sporanox Pulsepak
- Sprycel
- Tarceva
- Tasigna
Severe
Moderate
- Adderall
- Adderall Xr
- Amphetamine Salt Combo
- Astagraf Xl
- Ceftin
- cefuroxime axetil
- Celexa
- Dexedrine Spansule
- dextroamphetamine
- dextroamphetamine-amphetamine
- escitalopram oxalate
- Hecoria
- Isentress
- Lexapro
- Methotrexate (anti-rheumatic)
- Procentra
- Prograf
- raltegravir
- Rheumatrex
- tacrolimus
- Trexall
- Zenzedi
- None
Contraindicated
- Clostridium difficile infection
- Interstitial nephritis
- Severe hepatic disease
- Subacute cutaneous lupus erythematosus
- Systemic lupus erythematosus
Severe
Moderate
- CYp2c19 poor metabolizer
- Fracture
- Hypomagnesemia
- Osteoporosis
- Vitamin b12 deficiency
ESOMEP-EZS (esomeprazole magnesium/glycerin)
- None
- Acute abdominal pain
- Constipation
- Diarrhea
- Dizziness
- Flatulence
- Headache disorder
- Injection site sequelae
- Nausea
- Pruritus of skin
- Vertigo
More Frequent
Severe
Less Severe
- Sinusitis
- Dyspepsia
- Dyspnea
- Insomnia
- Pharyngitis
- Symptoms of anxiety
- Urinary tract infection
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Aggressive behavior
- Agitation
- Agranulocytosis
- Anaphylaxis
- Anemia
- Angioedema
- Arthralgias
- Atrial fibrillation
- Benign fundic gland polyposis of stomach
- Biliary calculus
- Blurred vision
- Bronchospastic pulmonary disease
- Clostridium difficile infection
- Depression
- Erythema multiforme
- Fracture
- Gastritis
- Gastroenteritis
- Gastrointestinal candidiasis
- Goiter
- Hallucinations
- Hepatic failure
- Hepatitis
- Herpes simplex infection
- Hypertension
- Increased alanine transaminase
- Increased aspartate transaminase
- Interstitial nephritis
- Jaundice
- Muscle weakness
- Myalgias
- Neutropenic disorder
- Pancreatitis
- Pancytopenia
- Skin inflammation
- Skin photosensitivity
- Stevens-johnson syndrome
- Stomatitis
- Subacute cutaneous lupus erythematosus
- Systemic lupus erythematosus
- Thrombocytopenic disorder
- Toxic epidermal necrolysis
- Urticaria
Less Severe
- Abdominal distension
- Alopecia
- Anorexia
- Back pain
- Bradycardia
- Chest pain
- Chills
- Colitis
- Dehydration
- Drowsy
- Dysgeusia
- Dysphagia
- Edema
- Facial edema
- Fatigue
- Fever
- Flu-like symptoms
- Flushing
- General weakness
- Gynecomastia
- Hyperhidrosis
- Hypomagnesemia
- Increased appetite
- Increased defecation frequency
- Increased urinary frequency
- Malaise
- Pain
- Palpitations
- Peripheral edema
- Tachycardia
- Tenesmus
- Upper respiratory infection
- Vitamin b12 deficiency
- Weight gain
- Weight loss
Contraindicated
None
Severe Precaution
Esomeprazole
Safety and efficacy not established.
- 1 Day – 29 Days
- Safety and efficacy not established.
Management or Monitoring Precaution
Esomeprazole
Increased incidence of tachypnea, regurgitation and increased ALT in patients age < 1 year.
- 30 Days – 364 Days
- Increased incidence of tachypnea, regurgitation and increased ALT in patients age < 1 year.
Esomeprazole
- Severity Level:
2
- Additional Notes: Insufficient human data avail; animal data do not sug dev tox
Glycerin
- Severity Level:
2
- Additional Notes: Insufficient data available
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Esomeprazole
Insufficient human data avail; similar drug omeprazole excreted at low levels
Insufficient data available; likely compatible per briggs
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data avail; similar drug omeprazole excreted at low levels |
Glycerin
Insufficient human data avail; similar drug omeprazole excreted at low levels
Insufficient data available; likely compatible per briggs
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; likely compatible per briggs |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None